Physician profile
Thomas J Flautt
NPI 1215342241
$74,283.23
in general payments reported to CMS, 2019-2025
46 companies · $19K in 2025
The $19K reported for 2025 was more than what 88% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,515 · 2020: $662 · 2021: $27K · 2022: $5,683 · 2023: $6,296 · 2024: $9,074 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $10K · Travel and Lodging: $10K · Education: $7.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,237.10 |
| Consulting Fee | $10,197.30 |
| Travel and Lodging | $10,018.93 |
| Education | $7.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,053.49 | 2021-2025 | Affera Mapping System, Pulseselect, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $20,265.99 | 2020-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $6,788.22 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $5,251.01 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Biotronik INC. | $2,954.35 | 2019-2025 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $867.42 | 2019-2025 | |
| Philips North America LLC | $655.01 | 2022-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, Mcot |
| Amgen INC. | $512.76 | 2019-2025 | Repatha |
| Impulse Dynamics (USA) INC. | $510.40 | 2022-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $415.67 | 2022-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $392.90 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.93 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.18 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $333.06 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $279.03 | 2020-2025 | Farxiga, Andexxa, Wainua |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $270.48 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $245.41 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Medtronic Vascular, INC. | $210.13 | 2019-2020 | |
| Elutia, INC. | $171.44 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.66 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $150.59 | 2022-2023 | |
| Abiomed | $137.27 | 2024-2025 | Impella |
| Heartflow, INC. | $95.73 | 2023 | Ffrct |
| Inspire Medical Systems, INC. | $87.10 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $74.00 | 2019-2025 | Evkeeza |
| Penumbra, INC. | $56.16 | 2024 | Indigo System |
| Lexicon Pharmaceuticals, INC. | $48.46 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $47.73 | 2025 | Attruby |
| Terumo Medical Corporation | $45.91 | 2024-2025 | Glidewire |
| Irhythm Technologies, INC. | $45.48 | 2022-2023 | Zio Xt Patch |
| Edwards Lifesciences Corporation | $43.98 | 2025 | |
| Cardiva Medical, INC. | $42.84 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $33.61 | 2021-2025 | Barostim Neo System |
| Scpharmaceuticals INC. | $32.73 | 2024 | |
| Altathera Pharmaceuticals LLC | $32.07 | 2022 | |
| Portola Pharmaceuticals, LLC | $26.37 | 2019 | |
| W. L. Gore & Associates, INC. | $23.32 | 2025 | Gore Cardioform Asd Occluder |
| Alnylam Pharmaceuticals INC. | $22.86 | 2025 | Amvuttra |
| Baxter Healthcare | $22.15 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Ge Healthcare | $20.76 | 2019 | |
| Convatec INC. | $20.15 | 2019 | |
| Stryker Corporation | $18.38 | 2025 | Flowtriever |
| Astellas Pharma US INC | $18.35 | 2019 | |
| Glaxosmithkline, LLC. | $18.24 | 2025 | Shingrix, Arexvy |
| Esperion Therapeutics, INC. | $17.45 | 2024 | Nexletol |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Flautt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.